These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29137260)

  • 41. Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma.
    Xu JZ; Gong C; Xie ZF; Zhao H
    Front Oncol; 2020; 10():593022. PubMed ID: 33585210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma.
    Zhang Y; Li J; Wang R; Li Y; Pan Y; Cai D; Hu H; Li H; Ye T; Luo X; Zhang Y; Li B; Shen L; Sun Y; Chen H
    Sci Rep; 2014 Nov; 4():7163. PubMed ID: 25418354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile.
    De Oliveira Duarte Achcar R; Nikiforova MN; Yousem SA
    Am J Clin Pathol; 2009 May; 131(5):694-700. PubMed ID: 19369630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
    J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Papillary predominant histological subtype predicts poor survival in lung adenocarcinoma.
    Yaldız D; Acar A; Örs Kaya Ş; Aydoğdu Z; Gürsoy S; Yaldız S
    Turk Gogus Kalp Damar Cerrahisi Derg; 2019 Jul; 27(3):360-366. PubMed ID: 32082885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic relevance of TTF-1 expression in stage I adenocarcinoma.
    Zhou C; Zhao J; Shao J; Li W
    Oncotarget; 2017 Dec; 8(64):107462-107468. PubMed ID: 29296178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymph node involvement according to lung adenocarcinoma subtypes: lymph node involvement is influenced by lung adenocarcinoma subtypes.
    Park JK; Kim JJ; Moon SW; Lee KY
    J Thorac Dis; 2017 Oct; 9(10):3903-3910. PubMed ID: 29268400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histology and oncogenic driver alterations of lung adenocarcinoma in Chinese.
    Shang G; Jin Y; Zheng Q; Shen X; Yang M; Li Y; Zhang L
    Am J Cancer Res; 2019; 9(6):1212-1223. PubMed ID: 31285953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncogenic Alterations in Histologically Negative Lymph Nodes Are Associated with Prognosis of Patients with Stage I Lung Adenocarcinoma.
    Tian Y; Lai Q; Zheng Y; Ying L; Wang C; Jin J; Huang M; Wu Y; Li H; Zhang J; Su D
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159091
    [No Abstract]   [Full Text] [Related]  

  • 50. Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma.
    Zhang J; Shao J; Zhu L; Zhao R; Xing J; Wang J; Guo X; Tu S; Han B; Yu K
    Oncotarget; 2017 Sep; 8(43):74846-74855. PubMed ID: 29088828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines.
    Lam DC; Luo SY; Deng W; Kwan JSh; Rodriguez-Canales J; Cheung AL; Cheng GH; Lin CH; Wistuba II; Sham PC; Wan TS; Tsao SW
    Onco Targets Ther; 2015; 8():195-209. PubMed ID: 25653542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pro-tumoural CXCL10/CXCR3-A autocrine loop in invasive mucinous lung adenocarcinoma.
    Duruisseaux M; Rabbe N; Antoine M; Vieira T; Poulot V; Cadranel J; Wislez M
    ERJ Open Res; 2017 Jan; 3(1):. PubMed ID: 28845427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MCM7 expression is correlated with histological subtypes of lung adenocarcinoma and predictive of poor prognosis.
    Wang H; Zhou C; Su B; Teng G; Zheng Y; Zhou X; Guo L; Xu F; Wang X
    Int J Clin Exp Pathol; 2017; 10(12):11747-11753. PubMed ID: 31966536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive investigation of clinicopathologic features, oncogenic driver mutations and immunohistochemical markers in peripheral lung squamous cell carcinoma.
    Zhang Y; Zheng D; Li Y; Pan Y; Sun Y; Chen H
    J Thorac Dis; 2017 Nov; 9(11):4434-4440. PubMed ID: 29268512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequent
    Trombetta D; Graziano P; Scarpa A; Sparaneo A; Rossi G; Rossi A; Di Maio M; Antonello D; Mafficini A; Fabrizio FP; Manzorra MC; Balsamo T; Centra F; Simbolo M; Pantalone A; Notarangelo M; Parente P; Lucia Dimitri MC; Bonfitto A; Fiordelisi F; Storlazzi CT; L'Abbate A; Taurchini M; Maiello E; Fazio VM; Muscarella LA
    Oncotarget; 2018 Feb; 9(11):9661-9671. PubMed ID: 29515761
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinicopathological Features and Survival Outcomes of Primary Pulmonary Invasive Mucinous Adenocarcinoma.
    Gow CH; Hsieh MS; Liu YN; Lee YH; Shih JY
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma.
    Xu X; Shen W; Wang D; Li N; Huang Z; Sheng J; Rucker AJ; Mao W; Xu H; Cheng G
    Transl Lung Cancer Res; 2022 Mar; 11(3):420-431. PubMed ID: 35399567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The first case of micropapillary adenocarcinoma associated with cystic airspace in a non-smoking man.
    Takahashi S; Murata S; Seki R; Kuriyama S; Kaji M; Nakamura M
    Respirol Case Rep; 2020 Mar; 8(2):e00513. PubMed ID: 31867109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of the Novel Grading System of Invasive Pulmonary Adenocarcinoma in a Real Diagnostic Scenario: A Brief Report of 9353 Cases.
    She Y; Zhong Y; Hou L; Zhao S; Zhang L; Xie D; Zhu Y; Wu C; Chen C
    JTO Clin Res Rep; 2023 Mar; 4(3):100465. PubMed ID: 36895916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Invasive mucinous adenocarcinoma misdiagnosed as pneumonia: A case report.
    Yang Y; Huang R; Xiang L; Zeng J; Zhao W; Huang N
    Exp Ther Med; 2023 Apr; 25(4):168. PubMed ID: 36936707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.